Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MicroRNA 516a-2 is a small non-coding RNA molecule encoded by the human MIR516A2 gene. Its main function is to regulate gene expression at the post-transcriptional level by binding to target mRNAs, leading to inhibition of translation or degradation of the mRNA. Like other miRNAs, MIR516A2 is processed from a precursor RNA through multiple enzymatic steps (e.g., Drosha, Dicer), and incorporated into the RNA-induced silencing complex (RISC) for its regulatory activity[4]. The specific biological targets and functions of MIR516A2 in humans are not as well characterized as for some other miRNAs, but it is part of a large miRNA family broadly involved in gene regulatory networks impacting cell proliferation, differentiation, and apoptosis[2][4][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on microRNA 516a-2 (MIR516A2).